Brain-derived uroguanylin as a regulator of postprandial brown adipose tissue activation: a potential therapeutic approach for metabolic disorders.

Habek, Nikola et al.·Frontiers in pharmacology·2025·
RPEP-112432025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Brain-derived uroguanylin as a regulator of postprandial brown adipose tissue activation: a potential therapeutic approach for metabolic disorders.
Published In:
Frontiers in pharmacology, 16, 1569163 (2025)
Database ID:
RPEP-11243

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11243·https://rethinkpeptides.com/research/RPEP-11243

APA

Habek, Nikola; Ratko, Martina; Sedmak, Dora; Banovac, Ivan; Crljen, Vladiana; Kordić, Milan; Radmilović, Marina; Škokić, Siniša; Tkalčić, Martina; Mažuranić, Anton; Bubalo, Pero; Škavić, Petar; Ljubić, Spomenka; Rahelić, Dario; Dugandžić, Aleksandra. (2025). Brain-derived uroguanylin as a regulator of postprandial brown adipose tissue activation: a potential therapeutic approach for metabolic disorders.. Frontiers in pharmacology, 16, 1569163. https://doi.org/10.3389/fphar.2025.1569163

MLA

Habek, Nikola, et al. "Brain-derived uroguanylin as a regulator of postprandial brown adipose tissue activation: a potential therapeutic approach for metabolic disorders.." Frontiers in pharmacology, 2025. https://doi.org/10.3389/fphar.2025.1569163

RethinkPeptides

RethinkPeptides Research Database. "Brain-derived uroguanylin as a regulator of postprandial bro..." RPEP-11243. Retrieved from https://rethinkpeptides.com/research/habek-2025-brainderived-uroguanylin-as-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.